secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2025-12-30T23:59:59+00:00
Accession:  0001493152-25-029482
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ENvue Medical amends 2024 Long Term Incentive Plan for Israeli tax compliance and name change
--------------------------------------------------------------------------------

- Board approved amended and restated 2024 Long Term Incentive Plan on December 24, 2025.
- Adds restricted stock units under Section 102 for Israeli tax compliance; other non-material updates.
- Reflects company name change from NanoVibronix to ENvue Medical and prior stockholder-approved amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315225029482/0001493152-25-029482-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315225029482/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-029482

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer